StockData
UTMDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

UTAH MEDICAL PRODUCTS INC

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$74.55+0.04 (+0.05%)

Close on Oct 19, 2026

Market cap
$237.37M
P/E (TTM)
22.7
Dividend yield
–

About Utah Medical Products

Surgical & Medical Instruments & Apparatus, SIC 3841

Utah Medical Products, Inc. manufactures and markets specialized medical devices designed to improve patient safety and clinical outcomes. The company's products span critical care sectors, including labor and delivery, neonatal intensive care, and gynecology, electrosurgery, and urology. Offerings include fetal monitoring accessories, intrauterine pressure catheters, vacuum-assisted delivery systems, infant respiratory hoods, enteral feeding devices, and electrosurgical systems such as loop electrodes and generators. Its customers primarily consist of clinical end-user facilities, hospitals, outpatient clinics, and physician offices, alongside designated stocking distributors and medical device companies utilizing subcontract manufacturing.

The company operates manufacturing and distribution facilities across the United States, Ireland, the United Kingdom, Canada, Australia, and New Zealand. Outside the United States, products reach end-users directly and through approximately 200 independent distributors across major developed and developing markets worldwide. Utah Medical Products, Inc. maintains its corporate headquarters in Midvale, Utah.

Summary of the business section of Utah Medical Products's latest annual report, written by StockData.

Company profile

Company

Legal name
UTAH MEDICAL PRODUCTS INC
Founded
1978
Headquarters
Midvale, UT
Address
7043 S 300 West 84070
Phone
(801) 521-5301
Employees
140, Dec 31, 2025
Industry
Surgical & Medical Instruments & Apparatus
Incorporated in
Utah
Fiscal year ends
December 31
Auditor
Haynie & Company, Salt Lake City, Utah

Stock & identifiers

Ticker
UTMD
Exchange
Nasdaq
Shares outstanding
3M, Aug 11, 2026
Public float
$168.20M, Jun 30, 2025
Filer category
Non-accelerated filer<br>Smaller reporting company
SEC CIK
706698
CUSIP
917488108
ISIN
US9174881089
LEI
5493002R27BBGV8DID60
EIN
87-0342734

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Brian KoopmanPrincipal Financial Officer782
Paul O. RichinsDirector43,144
Kevin TimkenDirector–
Carrie LeighDirector51

Employees

Headcount reported in annual reports

“At December 31, 2025, the Company worldwide had 140 full-time employees, 12 part-time employees, 7 regular consultants, 15 independent sales representatives and 9 outside (non-employee) directors of UTMD or its subsidiaries.”

Corporate history

Events identified from SEC filings